Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Juvenile Osteochondritis Dissecans of the Knee
NCT02397278Completed
- Sponsor
- University of Colorado Denver
- Start
- Mar 2015
- Primary completion
- Jan 2020
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Randomised, open-label trial of autologous platelet-rich plasma in osteochondritis dissecans (OCD) (2 arms), sponsored by University of Colorado Denver. Primary endpoint: Greater Cartilage Healing Measured by Glycosaminoglycan Content on dGEMRIC MRI at 6 months. Started Mar 2015; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
osteochondritis dissecans (OCD)
Beyond the preview
Go deeper on NCT02397278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02397278.